Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this research is to evaluate the use of the research study device, the Apple Vision Pro head-mounted spatial computing display, with the Zeiss Artevo 850 digital microscope system, for the visualization during cataract and anterior segment surgery. Specifically, researchers will assess how the study device affects surgical staff experience and workflow and monitor for patient safety and intraoperative complications associated with the use of the device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2025
CompletedFirst Posted
Study publicly available on registry
December 24, 2025
CompletedStudy Start
First participant enrolled
March 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 10, 2026
March 16, 2026
December 1, 2025
6 months
December 6, 2025
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative safety during head-mounted spatial computing visualization
Safety will be assessed by the proportion of surgical cases completed using head-mounted spatial computing visualization without conversion to standard microscope visualization due to device-related issues, and by the occurrence of intraoperative complications potentially related to visualization, including posterior capsule rupture, vitreous loss, corneal or scleral injury, or other unplanned intraoperative events.
Perioperative
Secondary Outcomes (4)
Surgeon workload during ocular surgery
Immediately after surgery
Surgeon-reported visualization quality and ergonomics
Immediately after surgery
Operating room staff workflow and usability
Immediately after surgery
Operative time and setup efficiency
Perioperative
Study Arms (1)
Spatial computing visualization of cataract and anterior segment eye surgery
EXPERIMENTALParticipants undergo standard-of-care cataract or anterior segment ocular surgery with adjunctive use of head-mounted spatial computing visualization. There is no comparison group.
Interventions
FDA-cleared digital ophthalmic surgical microscope used as standard of care to visualize the operative eye during cataract and anterior segment surgery. The microscope provides the primary intraoperative imaging source for all cases, regardless of visualization display method.
Head-mounted spatial computing display used by the surgeon to view the real-time video output from the Zeiss Artevo digital surgical microscope. The Apple Vision Pro functions solely as an alternative visualization interface and does not acquire images, alter microscope function, modify surgical technique, or affect patient care.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older
- Scheduled to undergo elective anterior segment eye surgery, including: cataract surgery, pterygium excision, corneal epithelial polishing
- Able and willing to provide informed consent prior to participation.
You may not qualify if:
- Complex ocular pathology that could interfere with surgical visualization or increase procedural risk, including but not limited to:
- Lens zonular instability or phacodonesis
- Prior vitreoretinal surgery (e.g., vitrectomy, scleral buckle, glaucoma drainage device) in the operative eye
- Significant corneal scarring, opacity, or edema
- Active ocular surface inflammation or infection
- Cognitive impairment or language barriers that prevent the patient from understanding and signing informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sharp HealthCarelead
Study Sites (1)
Sharp Otay Lakes Surgery Center
San Diego, California, 91914, United States
Related Publications (5)
Brooke, J. (1996). SUS: A quick and dirty usability scale. In P. W. Jordan, B. Thomas, B. A. Weerdmeester, & I. L. McClelland (Eds.), Usability Evaluation in Industry (pp. 189-194). London: Taylor & Francis.
BACKGROUNDHart, S. G., & Staveland, L. E. (1988). Development of NASA-TLX (Task Load Index): Results of empirical and theoretical research. In P. A. Hancock & N. Meshkati (Eds.), Human Mental Workload (pp. 139-183). Amsterdam: North-Holland.
BACKGROUNDMastropasqua R, Ruggeri ML, Quarta A, Tartaro R, Vecchiarino L, Corboli LV, Brescia L, Orione M, Russo A, Avitabile T, Mastropasqua L. New Mixed Reality Headset: First Exploratory Use in Intraocular Surgery and Telementoring. Ophthalmol Ther. 2025 Jul;14(7):1597-1609. doi: 10.1007/s40123-025-01117-y. Epub 2025 Apr 11.
PMID: 40214829BACKGROUNDBroderick RC, Spurzem GJ, Jeffery Reeves J, Hollandsworth HM, Sandler BJ, Jacobsen GR, Longhurst CA, Horgan S. First use of augmented reality headset in minimally invasive general surgery: seeing is believing. Surg Endosc. 2025 Sep;39(9):6055-6060. doi: 10.1007/s00464-025-11985-x. Epub 2025 Jul 10.
PMID: 40640628BACKGROUNDSuh Y, Shin S, Kim BY, Jeong J, Kim TI. Comparison of neck angle and musculoskeletal discomfort of surgeon in cataract surgery between three-dimensional heads-up display system and conventional microscope. Sci Rep. 2024 Sep 30;14(1):22681. doi: 10.1038/s41598-024-68630-1.
PMID: 39349516BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tommy Korn, MD
Sharp Rees-Stealy Medical Group and Sharp HealthCare
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ophthalmologist - Sharp Rees-Stealy Medical Group
Study Record Dates
First Submitted
December 6, 2025
First Posted
December 24, 2025
Study Start
March 11, 2026
Primary Completion (Estimated)
September 10, 2026
Study Completion (Estimated)
September 10, 2026
Last Updated
March 16, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared to protect patient confidentiality. Only aggregated, de-identified data will be published in scientific reports on visualization performance, workflow, and surgeon and operating room staff feedback.